Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

1.8K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Single-port robotic-assisted partial splenectomy for a giant congenital splenic cyst in a child using the SHURUI system.

Frontiers in pediatrics·2026
Same author

Functional anti-preS1 antibody responses associated with viral control in chronic hepatitis B.

Gut·2026
Same author

<i>NDUFS6</i> promotes neuroblastoma progression and represents a potential therapeutic target.

Translational pediatrics·2026
Same author

An insight into mechanical properties of alkaline minerals (eitelite and shortite) deposited in Fengcheng Formation, Mahu Sag.

Fundamental research·2026
Same author

Intermittent fasting alleviates ulcerative colitis via lithocholic acid-mediated macrophage reprogramming.

Frontiers in nutrition·2026
Same author

Single-port robotic resection of gliomatosis peritonei following immature ovarian teratoma in an adolescent: A case report.

Gynecologic oncology reports·2026

Related Experiment Video

Updated: Jul 27, 2025

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.2K

Soluble NKG2D ligands impair CD8

Yi Zhang1, Feifei Luo2,3, Kuiran Dong1

  • 1Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai 201102, P.R. China.

Oncology Letters
|June 5, 2023
PubMed
Summary
This summary is machine-generated.

Neuroblastoma tumors use soluble NKG2D ligands (NKG2DL) to evade T cell immunity. Blocking these NKG2DLs restores CD8+ T cell function, offering a new immunotherapy strategy for neuroblastoma.

Keywords:
NKG2D receptora disintegrin and metalloproteinasesneuroblastomasoluble NKG2DL

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.0K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K

Related Experiment Videos

Last Updated: Jul 27, 2025

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.2K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.0K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • T cell immunotherapy shows promise but faces challenges in tumor immune escape.
  • Neuroblastoma (NB) utilizes tumor-derived NKG2D ligands (NKG2DL) for immune evasion, but mechanisms are unclear.

Purpose of the Study:

  • Investigate the role of soluble NKG2DL in NB immune escape.
  • Determine the impact of soluble NKG2DL on T cell function.
  • Evaluate blocking soluble NKG2DL as a therapeutic strategy.

Main Methods:

  • Measured soluble NKG2DL (sMICA, sULBP-2) in NB patient serum and cell line supernatants.
  • Assessed the effect of soluble NKG2DL on CD8+ T cell function (NKG2D degradation, proliferation, IFN-γ production, CD107a translocation).
  • Tested the efficacy of sNKG2DL neutralizing antibodies in enhancing anti-tumor activity.

Main Results:

  • Soluble NKG2DL expression correlated with immunosuppression and poor prognosis in NB.
  • NB-derived soluble NKG2DL degraded NKG2D on CD8+ T cells, impairing their function.
  • Blocking soluble NKG2DL enhanced CD8+ T cell anti-tumor activity.

Conclusions:

  • Neuroblastoma employs soluble NKG2DL (sMICA, sULBP-2) to create an immunosuppressive environment.
  • Neutralizing antibodies against soluble NKG2DL represent a novel strategy to restore T cell function and improve immunotherapy for NB.